Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with primary or secondary liver cancer (cancer that started in the liver, or cancer that has spread to the liver from elsewhere).
- People whose overall health and activity level falls within a moderate range — specifically, an ECOG Performance Status score of 0 to 2 (confirm with trial site for what this means in your situation).
- People who are 18 years of age or older and under 100 years of age.
- People who are expected to live for at least 3 more months.
- People whose liver cancer has been assessed as not suitable for surgery to remove the tumour or for a liver transplant.
- People who are able to understand and sign a consent form explaining what the study involves.
- People who are willing and able to follow all study requirements, including attending all procedures, medical check-ups, and follow-up visits.
Who may not be able to join:
- People whose liver is not functioning well enough — specifically those with a Child-Pugh C classification, moderate to severe fluid build-up in the abdomen, blood clotting problems, or severe liver scarring (confirm with trial site).
- People with certain blood test results showing the liver is under significant stress — specifically, liver enzyme levels (AST or ALT) more than 5 times the normal upper limit, or a bilirubin level above 2.0 mg/dL (confirm with trial site).
- People who have a bleeding disorder.
- People who have had an allergic reaction or serious intolerance to contrast dyes used in medical imaging scans.
- People who have a serious, life-threatening illness or disease outside of the liver.
- People with other health conditions — physical or mental — that the study doctor believes could prevent the treatment from working or could put the person at risk, such as an active infection, kidney problems, or significant ongoing illness.
- People with a significant mental health condition.
- Women who are pregnant, breastfeeding, or planning to become pregnant within the next 6 months.
- People who are currently enrolled in another study involving a medical device, drug, or procedure that could affect the results of this trial.
- People whose liver tumours do not show uptake of contrast dye on specific types of imaging scans (CT or MR angiography).
- People whose liver tumours do not show a high level of blood supply when viewed on angiography imaging.
- People who do not have CT or MRI scan results available at their screening visit, or who are unwilling or unable to have MRI scans during the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fatih Selcukbiricik, MD, Koc University Hospital
Phone: +90 850-250-8250
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ablation; Adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.